1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020.
Br J Ophthalmol 2006;90:262-267.
2. Liesegang TJ. Glaucoma: changing concepts and future directions.
Mayo Clin Proc 1996;71:689-694.
3. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes.
Ophthalmology 1979;86:1803-1830.
4. Krakau CE. Intraocular pressure elevation-cause or effect in chronic glaucoma?
Ophthalmologica 1981;182:141-147.
5. Shen F, Chen B, Danias J, et al. Glutamate-induced glutamine synthetase expression in retinal Muller cells after short-term ocular hypertension in the rat.
Invest Ophthalmol Vis Sci 2004;45:3107-3112.
6. Chung HS, Harris A, Evans DW, et al. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy.
Surv Ophthalmol 1999;43(Suppl 1):S43-S50.
7. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma.
Prog Retin Eye Res 2002;21:359-393.
8. Butt Z, O'Brien C, McKillop G, et al. Color Doppler imaging in untreated high- and normal-pressure open-angle glaucoma. Invest Ophthalmol Vis Sci 1997;38:690-696.
9. Findl O, Rainer G, Dallinger S, et al. Assessment of optic disk blood flow in patients with open-angle glaucoma.
Am J Ophthalmol 2000;130:589-596.
10. Flammer J, Haefliger IO, Orgul S, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 1999;8:212-219.
11. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol 2007;52(Suppl 2):S162-S173.
12. Moreno MC, Campanelli J, Sande P, et al. Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 2004;37:803-812.
13. Galassi F, Renieri G, Sodi A, et al. Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma. Br J Ophthalmol 2004;88:757-760.
14. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci 1981;21:714-727.
15. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 1984;91:564-579.
16. Zhou L, Li Y, Yue BY. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J Cell Physiol 1999;180:182-189.
17. Sacca SC, Pascotto A, Camicione P, et al. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol 2005;123:458-463.
18. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 2001;7:304-309.
19. Sacca SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res 2007;84:389-399.
20. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res 2006;612:105-114.
21. Ko ML, Hu DN, Ritch R, Sharma SC. The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci 2000;41:2967-2971.
22. Tanito M, Nishiyama A, Tanaka T, et al. Change of redox status and modulation by thiol replenishment in retinal photooxidative damage. Invest Ophthalmol Vis Sci 2002;43:2392-2400.
23. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003;121:547-557.
24. Siskova A, Wilhelm J. The effects of hyperoxia, hypoxia, and ischemia/reperfusion on the activity of cytochrome oxidase from the rat retina. Physiol Res 2001;50:267-273.
25. Hirose F, Kiryu J, Miyamoto K, et al. In vivo evaluation of retinal injury after transient ischemia in hypertensive rats. Hypertension 2004;43:1098-1102.
26. Hanashima C, Namiki H. Reduced viability of vascular endothelial cells by high concentration of ascorbic acid in vitreous humor. Cell Biol Int 1999;23:287-298.
27. Brubaker RF, Bourne WM, Bachman LA, McLaren JW. Ascorbic acid content of human corneal epithelium. Invest Ophthalmol Vis Sci 2000;41:1681-1683.
28. Dreyer R, Rose RC. Lacrimal gland uptake and metabolism of ascorbic acid. Proc Soc Exp Biol Med 1993;202:212-216.
29. Ringvold A, Anderssen E, Kjonniksen I. Distribution of ascorbate in the anterior bovine eye. Invest Ophthalmol Vis Sci 2000;41:20-23.
30. Giblin FJ, McCready JP, Kodama T, Reddy VN. A direct correlation between the levels of ascorbic acid and H2O2 in aqueous humor. Exp Eye Res 1984;38:87-93.
31. Richer SP, Rose RC. Water soluble antioxidants in mammalian aqueous humor: interaction with UV B and hydrogen peroxide. Vision Res 1998;38:2881-2888.
32. Kahn MG, Giblin FJ, Epstein DL. Glutathione in calf trabecular meshwork and its relation to aqueous humor outflow facility. Invest Ophthalmol Vis Sci 1983;24:1283-1287.
33. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005;80:709-725.
34. Yildirim O, Ates NA, Tamer L, et al. Changes in antioxidant enzyme activity and malondialdehyde level in patients with age-related macular degeneration. Ophthalmologica 2004;218:202-206.
35. Chen JZ, Kadlubar FF. A new clue to glaucoma pathogenesis. Am J Med 2003;114:697-698.
36. Dringen R. Glutathione metabolism and oxidative stress in neurodegeneration. Eur J Biochem 2000;267:4903
37. Hall AG. Review: the role of glutathione in the regulation of apoptosis. Eur J Clin Invest 1999;29:238-245.
38. Riley MV. Physiologic neutralization mechanisms and the response of the corneal endothelium to hydrogen peroxide. CLAO J 1990;16(1 Suppl):S16-S21.
39. Costarides AP, Riley MV, Green K. Roles of catalase and the glutathione redox cycle in the regulation of anterior-chamber hydrogen peroxide. Ophthalmic Res 1991;23:284-294.
40. Ferreira SM, Lerner SF, Brunzini R, et al. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004;137:62-69.
41. Yang J, Tezel G, Patil RV, et al. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci 2001;42:1273-1276.
42. Unal M, Guven M, Devranoglu K, et al. Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population. Br J Ophthalmol 2007;91:527-530.
43. Gherghel D, Griffiths HR, Hilton EJ, et al. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2005;46:877-883.
44. Roh YJ, Moon C, Kim SY, et al. Glutathione depletion induces differential apoptosis in cells of mouse retina, in vivo. Neurosci Lett 2007;417:266-270.
45. Park JW, Moon C, Yun S, et al. Differential expression of heat shock protein mRNAs under in vivo glutathione depletion in the mouse retina. Neurosci Lett 2007;413:260-264.
46. Choe YJ, Hong YJ. The prevalence of glaucoma in Korean careermen. J Korean Ophthalmol Soc 1993;34:153-158.
47. Iwase A, Suzuki Y, Araie M, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004;111:1641-1648.
48. Kim CS, Seong GJ, Lee NH, et al. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology 2011;118:1024-1030.
49. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-497.
50. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
51. In: Allingham RR, Shields MB, Neuroprotection and other investigational drugs. Shields' textbook of glaucoma. 2005. Philadelphia: Lippincott Williams & Wilkins; p. 512-515.
52. Brubaker RF. Delayed functional loss in glaucoma: LII Edward Jackson Memorial Lecture. Am J Ophthalmol 1996;121:473-483.
53. Akerboom TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981;77:373-382.
54. Nguyen KP, Weiss H, Karageuzian LN, et al. Glutathione reductase of calf trabecular meshwork. Invest Ophthalmol Vis Sci 1985;26:887-890.
55. Levin LA, Clark JA, Johns LK. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest Ophthalmol Vis Sci 1996;37:2744-2749.
56. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003;114:638-646.
57. Schutte M, Werner P. Redistribution of glutathione in the ischemic rat retina. Neurosci Lett 1998;246:53-56.
58. Carter-Dawson L, Shen FF, Harwerth RS, et al. Glutathione content is altered in Muller cells of monkey eyes with experimental glaucoma. Neurosci Lett 2004;364:7-10.
59. Kim SH, Park HM, Seo JH, Hur M. The change of blood reduced glutathione according to postmenopausal HRT: GSH as a marker of antioxidant effect of the sex steroids. J Korean Soc Menopause 1997;3:116-125.
60. Park DK, Jeong SK, Chung MG, et al. Glutathione levels in Helicobacter pylori-infected gastric mucosa. Korean J Gastroenterol 2003;42:267-273.